CAR T-cell therapy in Tel Aviv typically costs from $185,000 to $245,000. Prices vary based on whether the hospital uses a commercial brand or an in-house manufactured protocol. In the US, similar procedures cost around $525,000 on average. Patients save around 83% compared to the US, where this procedure is often significantly more expensive. Standard pricing in Tel Aviv clinics often includes cell collection, genetic engineering, and long-term inpatient monitoring.
- In-house manufacturing: Generally costs less than commercial products like Kymriah or Yescarta.
- Commercial drug products: Utilizing global brands typically adds significant costs due to acquisition fees.
- Hospital stay: Programs often include three weeks of hospitalization for side-effect monitoring.
- Medical evaluation: Initial diagnostic staging and bone marrow biopsies may be billed separately.
Bookimed Expert Insight: Tel Aviv is Israel's primary hub for clinical hematology. Sourasky Medical Center (Ichilov) holds a Newsweek Top World Specialized Clinics ranking. It offers institutional protocols that reduce costs compared to commercial drugs. Success is driven by specialists like Dr. Ron Ram, who is board-certified in hematology and oncology. These centers manage high volumes, treating over 400,000 patients annually with JCI-accredited safety standards.